Automated liquid culture system misses isoniazid heteroresistance in Mycobacterium tuberculosis isolates with mutations in the promoter region of the inhA gene

[1]  K. Kam,et al.  Ethambutol Resistance as Determined by Broth Dilution Method Correlates Better than Sequencing Results with embB Mutations in Multidrug-Resistant Mycobacterium tuberculosis Isolates , 2013, Journal of Clinical Microbiology.

[2]  L. Rigouts,et al.  Rifampin Heteroresistance in Mycobacterium tuberculosis Cultures as Detected by Phenotypic and Genotypic Drug Susceptibility Test Methods , 2013, Journal of Clinical Microbiology.

[3]  P. V. van Helden,et al.  Population Structure of Mixed Mycobacterium tuberculosis Infection Is Strain Genotype and Culture Medium Dependent , 2013, PloS one.

[4]  L. Rigouts,et al.  Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations , 2013, Journal of Clinical Microbiology.

[5]  Suhua Zheng,et al.  Combining COLD-PCR and high-resolution melt analysis for rapid detection of low-level, rifampin-resistant mutations in Mycobacterium tuberculosis. , 2013, Journal of microbiological methods.

[6]  S. Borrell,et al.  The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. , 2013, Trends in genetics : TIG.

[7]  L. Rigouts,et al.  Can Molecular Methods Detect 1% Isoniazid Resistance in Mycobacterium tuberculosis? , 2013, Journal of Clinical Microbiology.

[8]  E. Houpt,et al.  Digital PCR to Detect and Quantify Heteroresistance in Drug Resistant Mycobacterium tuberculosis , 2013, PloS one.

[9]  M. Ehlers,et al.  Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa , 2012, BMC Infectious Diseases.

[10]  Shengfen Wang,et al.  Study of the Rifampin Monoresistance Mechanism in Mycobacterium tuberculosis , 2012, Antimicrobial Agents and Chemotherapy.

[11]  Yu Wang,et al.  National survey of drug-resistant tuberculosis in China. , 2012, The New England journal of medicine.

[12]  B. Zhao,et al.  Spoligotyping and Drug Resistance Analysis of Mycobacterium tuberculosis Strains from National Survey in China , 2012, PloS one.

[13]  J. Palomino,et al.  Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. , 2011, The Journal of antimicrobial chemotherapy.

[14]  J. Bayona,et al.  Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis , 2010, The Lancet.

[15]  T. Kirikae,et al.  Identification of katG Mutations Associated with High-Level Isoniazid Resistance in Mycobacterium tuberculosis , 2010, Antimicrobial Agents and Chemotherapy.

[16]  A. Van Deun,et al.  Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  I. Bastian,et al.  Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results , 2009, Journal of Clinical Microbiology.

[18]  Diana C. Rostirolla,et al.  Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America , 2009, BMC Microbiology.

[19]  K. Feldmann,et al.  Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan , 2008, European Respiratory Journal.

[20]  E. Bouza,et al.  Characterization of Clonal Complexity in Tuberculosis by Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing , 2005, Journal of Clinical Microbiology.

[21]  F. Portaels,et al.  Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis , 2002, Antimicrobial Agents and Chemotherapy.

[22]  S. Gillespie,et al.  Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective , 2002, Antimicrobial Agents and Chemotherapy.

[23]  Robert H. Gilman,et al.  Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay , 1998, Journal of Clinical Microbiology.

[24]  H. David,et al.  Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. , 1970, Applied microbiology.

[25]  M. Aziz,et al.  Guidelines for surveillance of drug resistance in tuberculosis , 2009 .

[26]  A. Laszlo,et al.  Anti-tuberculosis drug resistance in the world. Fourth global report. The WHO / IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 2002-2007. , 2003 .